An Archetypical Model for Engrafting Bacteroides fragilis into Conventional Mice Following Reproducible Antibiotic Conditioning of the Gut Microbiota
Open Access
- 10 February 2023
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 11 (2) , 451
Abstract
Bacteroides fragilis is a commonly investigated commensal bacterium for its protective role in host diseases. Here, we aimed to develop a reproducible antibiotic-based model for conditioning the gut microbiota and engrafting B. fragilis into a conventional murine host. Initially, we selected different combinations of antibiotics, including metronidazole, imipenem, and clindamycin, and investigated their efficacy in depleting the mouse Bacteroides population. We performed 16S rRNA sequencing of DNA isolated from fecal samples at different time points. The α-diversity was similar in mice treated with metronidazole (MET) and differed only at weeks 1 (p = 0.001) and 3 (p = 0.009) during metronidazole/imipenem (MI) treatment. Bacteroides compositions, during the MET and MI exposures, were similar to the pre-antibiotic exposure states. Clindamycin supplementation added to MET or MI regimens eliminated the Bacteroides population. We next repeated metronidazole/clindamycin (MC) treatment in two additional independent experiments, followed by a B. fragilis transplant. MC consistently and reproducibly eliminated the Bacteroides population. The depleted Bacteroides did not recover in a convalescence period of six weeks post-MC treatment. Finally, B. fragilis was enriched for ten days following engraftment into Bacteroides-depleted mice. Our model has potential use in gut microbiota studies that selectively investigate Bacteroides’ role in diseases of interest.Keywords
Funding Information
- South Africa’s National Research Foundation (NRF) (145930)
- World Academy of Sciences (TWAS) (145930)
- Stellenbosch University (145930)
- South African Research Chair Initiative (SARChI) (145930)
This publication has 64 references indexed in Scilit:
- Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatmentGenome Biology, 2012
- Diversity, stability and resilience of the human gut microbiotaNature, 2012
- Structural characterization and MHCII-dependent immunological properties of the zwitterionic O-chain antigen of Morganella morganiiGlycobiology, 2011
- A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating diseaseMucosal Immunology, 2010
- Obesity and the human microbiomeCurrent Opinion in Gastroenterology, 2010
- Type I Streptococcus pneumoniae carbohydrate utilizes a nitric oxide and MHC II‐dependent pathway for antigen presentationImmunology, 2009
- Innate immunity and intestinal microbiota in the development of Type 1 diabetesNature, 2008
- A microbial symbiosis factor prevents intestinal inflammatory diseaseNature, 2008
- Bacteroides: the Good, the Bad, and the Nitty-GrittyClinical Microbiology Reviews, 2007
- An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune SystemCell, 2005